R, N. Et Al. 2023. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.. Rheumatology (Oxford, England) , vol.62, no.7 , 2453-2463.

R, N., Nikiphorou, E., Joshi, M., Sen, P., Lindblom, J., Agarwal, V., ... Lilleker, J. B.(2023). Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.. Rheumatology (Oxford, England) , vol.62, no.7, 2453-2463.

R, Naveen Et Al. "Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.," Rheumatology (Oxford, England) , vol.62, no.7, 2453-2463, 2023

R, Naveen Et Al. "Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.." Rheumatology (Oxford, England) , vol.62, no.7, pp.2453-2463, 2023

R, N. Et Al. (2023) . "Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.." Rheumatology (Oxford, England) , vol.62, no.7, pp.2453-2463.

@article{article, author={Naveen R Et Al. }, title={Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.}, journal={Rheumatology (Oxford, England)}, year=2023, pages={2453-2463} }